Coelho Philip H's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Sep 15, 2022
- Accession no.
- 0001161697-22-000455
- Filed
- Sep 15, 2022
- Trade date
- Sep 13-14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $472.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coelho Philip HCIK 0001109775 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −10,000 | $15.70 | −$157,000 | 269,553 | Direct | |
| Sep 14, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −20,000 | $15.75F2 | −$315,000 | 249,553 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price for the shares sold. Shares were sold at prices ranging from $15.70 to $15.80 per share.
Referenced by the price of 1 transaction in Table I.